Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Nanotechnology Drug Delivery Systems Market by Type (Nanocrystals, Nanoparticles, Dendrimers, Gold Nanoparticles, Fullerenes, Liposomes, Nanotubes, Others), By Application (Immunology, Cardiovascular, Neurology, Oncology, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Nanotechnology Drug Delivery Systems Market by Type (Nanocrystals, Nanoparticles, Dendrimers, Gold Nanoparticles, Fullerenes, Liposomes, Nanotubes, Others), By Application (Immunology, Cardiovascular, Neurology, Oncology, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 252464 4200 Medical Care 377 122 Pages 4.8 (36)
                                          

Industry Growth Insights published a new data on “Nanotechnology Drug Delivery Systems Market”. The research report is titled “Nanotechnology Drug Delivery Systems Market research by Types (Nanocrystals, Nanoparticles, Dendrimers, Gold Nanoparticles, Fullerenes, Liposomes, Nanotubes, Others), By Applications (Immunology, Cardiovascular, Neurology, Oncology, Others), By Players/Companies AbbVie, Inc., Amgen Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Perrigo Company plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., 3M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Nanotechnology Drug Delivery Systems Market Research Report

By Type

Nanocrystals, Nanoparticles, Dendrimers, Gold Nanoparticles, Fullerenes, Liposomes, Nanotubes, Others

By Application

Immunology, Cardiovascular, Neurology, Oncology, Others

By Companies

AbbVie, Inc., Amgen Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Perrigo Company plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., 3M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

122

Number of Tables & Figures

86

Customization Available

Yes, the report can be customized as per your need.


Global Nanotechnology Drug Delivery Systems Industry Outlook


Global Nanotechnology Drug Delivery Systems Market Report Segments:

The global Nanotechnology Drug Delivery Systems market is segmented on the basis of:

Types

Nanocrystals, Nanoparticles, Dendrimers, Gold Nanoparticles, Fullerenes, Liposomes, Nanotubes, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Immunology, Cardiovascular, Neurology, Oncology, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. AbbVie, Inc.
  2. Amgen Inc.
  3. Celgene Corporation
  4. Johnson & Johnson
  5. Merck & Co., Inc.
  6. Novartis International AG
  7. Perrigo Company plc
  8. Pfizer, Inc.
  9. Teva Pharmaceutical Industries Ltd.
  10. 3M
  11. Zosano Pharma
  12. Becton-Dickinson(BD)Technologies
  13. Nanopass Technologies
  14. Corium
  15. Valeritas
  16. Nitto
  17. Microdermics
  18. TheraJect
  19. Vaxxas
  20. Lohmann Therapie-Systeme AG

Global Nanotechnology Drug Delivery Systems Market Overview


Highlights of The Nanotechnology Drug Delivery Systems Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Nanocrystals
    2. Nanoparticles
    3. Dendrimers
    4. Gold Nanoparticles
    5. Fullerenes
    6. Liposomes
    7. Nanotubes
    8. Others
  1. By Application:

    1. Immunology
    2. Cardiovascular
    3. Neurology
    4. Oncology
    5. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Nanotechnology Drug Delivery Systems Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Nanotechnology Drug Delivery Systems Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Nanotechnology drug delivery systems are designed to improve the efficacy and safety of drugs by using nanoscale materials and devices. These systems can help reduce the amount of drug needed, increase its effectiveness, and decrease its side effects.

Some of the key players operating in the nanotechnology drug delivery systems market are AbbVie, Inc., Amgen Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Perrigo Company plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., 3M, Zosano Pharma, Becton-Dickinson(BD)Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nanotechnology Drug Delivery Systems Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Nanotechnology Drug Delivery Systems Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Nanotechnology Drug Delivery Systems Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Nanotechnology Drug Delivery Systems Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Nanotechnology Drug Delivery Systems Market Size & Forecast, 2018-2028       4.5.1 Nanotechnology Drug Delivery Systems Market Size and Y-o-Y Growth       4.5.2 Nanotechnology Drug Delivery Systems Market Absolute $ Opportunity

Chapter 5 Global Nanotechnology Drug Delivery Systems Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Nanotechnology Drug Delivery Systems Market Size Forecast by Type
      5.2.1 Nanocrystals
      5.2.2 Nanoparticles
      5.2.3 Dendrimers
      5.2.4 Gold Nanoparticles
      5.2.5 Fullerenes
      5.2.6 Liposomes
      5.2.7 Nanotubes
      5.2.8 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Nanotechnology Drug Delivery Systems Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Nanotechnology Drug Delivery Systems Market Size Forecast by Applications
      6.2.1 Immunology
      6.2.2 Cardiovascular
      6.2.3 Neurology
      6.2.4 Oncology
      6.2.5 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Nanotechnology Drug Delivery Systems Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Nanotechnology Drug Delivery Systems Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Nanotechnology Drug Delivery Systems Analysis and Forecast
   9.1 Introduction
   9.2 North America Nanotechnology Drug Delivery Systems Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Nanotechnology Drug Delivery Systems Market Size Forecast by Type
      9.6.1 Nanocrystals
      9.6.2 Nanoparticles
      9.6.3 Dendrimers
      9.6.4 Gold Nanoparticles
      9.6.5 Fullerenes
      9.6.6 Liposomes
      9.6.7 Nanotubes
      9.6.8 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Nanotechnology Drug Delivery Systems Market Size Forecast by Applications
      9.10.1 Immunology
      9.10.2 Cardiovascular
      9.10.3 Neurology
      9.10.4 Oncology
      9.10.5 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Nanotechnology Drug Delivery Systems Analysis and Forecast
   10.1 Introduction
   10.2 Europe Nanotechnology Drug Delivery Systems Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Nanotechnology Drug Delivery Systems Market Size Forecast by Type
      10.6.1 Nanocrystals
      10.6.2 Nanoparticles
      10.6.3 Dendrimers
      10.6.4 Gold Nanoparticles
      10.6.5 Fullerenes
      10.6.6 Liposomes
      10.6.7 Nanotubes
      10.6.8 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Nanotechnology Drug Delivery Systems Market Size Forecast by Applications
      10.10.1 Immunology
      10.10.2 Cardiovascular
      10.10.3 Neurology
      10.10.4 Oncology
      10.10.5 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Nanotechnology Drug Delivery Systems Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Nanotechnology Drug Delivery Systems Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Nanotechnology Drug Delivery Systems Market Size Forecast by Type
      11.6.1 Nanocrystals
      11.6.2 Nanoparticles
      11.6.3 Dendrimers
      11.6.4 Gold Nanoparticles
      11.6.5 Fullerenes
      11.6.6 Liposomes
      11.6.7 Nanotubes
      11.6.8 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Nanotechnology Drug Delivery Systems Market Size Forecast by Applications
      11.10.1 Immunology
      11.10.2 Cardiovascular
      11.10.3 Neurology
      11.10.4 Oncology
      11.10.5 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Nanotechnology Drug Delivery Systems Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Nanotechnology Drug Delivery Systems Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Nanotechnology Drug Delivery Systems Market Size Forecast by Type
      12.6.1 Nanocrystals
      12.6.2 Nanoparticles
      12.6.3 Dendrimers
      12.6.4 Gold Nanoparticles
      12.6.5 Fullerenes
      12.6.6 Liposomes
      12.6.7 Nanotubes
      12.6.8 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Nanotechnology Drug Delivery Systems Market Size Forecast by Applications
      12.10.1 Immunology
      12.10.2 Cardiovascular
      12.10.3 Neurology
      12.10.4 Oncology
      12.10.5 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Nanotechnology Drug Delivery Systems Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Nanotechnology Drug Delivery Systems Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Nanotechnology Drug Delivery Systems Market Size Forecast by Type
      13.6.1 Nanocrystals
      13.6.2 Nanoparticles
      13.6.3 Dendrimers
      13.6.4 Gold Nanoparticles
      13.6.5 Fullerenes
      13.6.6 Liposomes
      13.6.7 Nanotubes
      13.6.8 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Nanotechnology Drug Delivery Systems Market Size Forecast by Applications
      13.10.1 Immunology
      13.10.2 Cardiovascular
      13.10.3 Neurology
      13.10.4 Oncology
      13.10.5 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Nanotechnology Drug Delivery Systems Market: Competitive Dashboard
   14.2 Global Nanotechnology Drug Delivery Systems Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 AbbVie, Inc.
      14.3.2 Amgen Inc.
      14.3.3 Celgene Corporation
      14.3.4 Johnson & Johnson
      14.3.5 Merck & Co., Inc.
      14.3.6 Novartis International AG
      14.3.7 Perrigo Company plc
      14.3.8 Pfizer, Inc.
      14.3.9 Teva Pharmaceutical Industries Ltd.
      14.3.10 3M
      14.3.11 Zosano Pharma
      14.3.12 Becton-Dickinson(BD)Technologies
      14.3.13 Nanopass Technologies
      14.3.14 Corium
      14.3.15 Valeritas
      14.3.16 Nitto
      14.3.17 Microdermics
      14.3.18 TheraJect
      14.3.19 Vaxxas
      14.3.20 Lohmann Therapie-Systeme AG

Our Trusted Clients

Contact Us